$XPL

7 Best Silver Mining Penny Stocks to Buy

The article discusses silver’s outlook, citing Sprott that a structural supply deficit, rising industrial demand, and investor interest support a likely ongoing global silver market deficit, with mine supply down 7% since 2016. It then lists silver-related penny stocks under $5, including Solitario Resources (XPL) and Integra Resources (ITRG), highlighting recent drilling updates and Florida Canyon plan economics.

Original reporting
Published Jul 8, 2026, 3:45 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 8, 2026, 4:06 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
7 Best Silver Mining Penny Stocks to Buy — source image
Decision brief

The 30-second read

$XPLBullishLow
01

Why it matters

For XPL, the actionable near-term item is the stated expectation for initial assay results in early August. For ITRG, the updated feasibility and life-of-mine plan provides concrete reserve and production upgrades plus longer-duration visibility through 2033.

02

Market read

This is a promotional “best penny stocks” roundup, but it does include two issuer-specific updates with time-bound milestones and quantified plan outputs that can influence small-cap precious-metals positioning.

03

What to watch

Assay results and permitting outcomes are binary and can lag; feasibility-study assumptions (metal prices, costs) may not hold, especially in a volatile commodity tape.

Relevance 5/10Novelty 4/10Timing: Early-August assay window for XPL, and 2027 BLM EIS/ROD timing for ITRG DeLamar.

Background

The article frames silver as supported by a structural supply deficit and ongoing industrial demand, then lists sub-$5 small-cap miners with recent “noteworthy developments.”

Company-level read

Ticker impact

$XPLBullishMedium confidence
Context

Solitario says its 2026 Ponderosa drilling is well advanced and initial assay results are expected in early August.

Expected impact

Moderate upside bias into early-August assay readout; volatility likely around drilling progress updates.

Evidence & confidence

The article provides specific, time-bound milestones (assay timing) plus confirmation of two active drilling programs, which can re-rate small-cap precious-metals names.

$ITRGBullishHigh confidence
Context

Integra reports an updated Florida Canyon feasibility plan, including a 74% increase in Proven and Probable reserves and production extended through 2033.

Expected impact

Positive medium-term repricing potential as investors digest higher reserves, longer mine life, and cash-flow estimates.

Evidence & confidence

The text includes concrete plan outputs (reserves, production extension, after-tax NPV/FCF figures) that are directly decision-relevant for the issuer.

Market effects

Reinforces the silver-supply-deficit bull case, which can lift sentiment for small-cap precious-metals developers even when not pure-play silver.

Primarily US-focused exploration and permitting updates (South Dakota, Nevada, Idaho, Colorado).

Limited direct global linkage; impacts are mostly via investor risk appetite for upstream precious-metals exposure.

Counterpoint

These are not pure-play silver miners, so silver price moves may not translate cleanly into earnings power; dilution/financing risk can dominate.

Key entities

  • Solitario Resources Corp.

    Announced progress on its 2026 Ponderosa drilling and plans for Cat Creek and Bright Angel permitting.

  • Integra Resources Corp.

    Released an updated feasibility study and life-of-mine plan for Florida Canyon, extending mining through 2033.

  • Sprott

    Cited for a silver bull-case narrative around supply deficit and industrial demand.

  • WisdomTree

    Cited for expectations of continued multi-year deficits and limited scope for higher mine output.

Related articles

$ITRGMedAI 8/10

Integra Resources (ITRG) Q2 2026 Earnings Call Transcript

Integra Resources (ITRG) reported Q2 2026 earnings with record gold production (16.4K oz), revenue ($70.8M), and operating cash flow ($22.8M). The company maintained annual gold production guidance (70K-75K oz). Florida Canyon's updated life of mine plan shows increased reserves, extended mine life, and improved cash flow. DeLamar project advances through federal permitting.

$ITRGMedAI 8/10

INTEGRA REPORTS SECOND QUARTER 2026 RESULTS; 30% INCREASE IN QUARTERLY GOLD PRODUCTION, RECORD TOTAL TONNES MINED AND STRENGTHENED FINANCIAL POSITION

Integra Resources Corp. reported Q2 2026 results for the three months ended June 30, 2026. Gold production at Florida Canyon rose 30% quarter over quarter to 16,379 oz, with revenue of $70.8 million and adjusted earnings of $13.1 million ($0.06/share). Cash and cash equivalents were $111.1 million. The company reiterated full-year guidance of 70,000 to 75,000 oz and filed an updated Florida Canyon feasibility study.

$ITRGMed

INTEGRA FILES FEASIBILITY STUDY AND UPDATED LIFE OF MINE PLAN TECHNICAL REPORT FOR THE PRODUCING FLORIDA CANYON MINE

TSXV: ITR; NYSE American: ITRG www.integraresources.com VANCOUVER, BC, July 30, 2026 /PRNewswire/ -- Integra Resources Corp. ("Integra" or the "Company") (TSXV: ITR) (NYSE American: ITRG) is pleased to announce that, further to its news release dated June 25, 2026, it has filed a Feasibility Study Technical Report and updated Life of Mine Plan (the "Technical Report") for the operating Florida Canyon Mine ("Florida Canyon" or the "Mine"), located in Pershing County, Nevada.

$ITRGMed

Integra study boosts Florida Canyon mine life

Integra Resources updated the feasibility study for its Florida Canyon gold mine in Nevada, reporting a 74% rise in mineral reserves to 1.19 million oz and higher expected production (70,000 to 82,000 oz/year). After-tax NPV is $601M at base metal prices and $723M at spot prices. The company expects $800M free cash flow over eight years and revised 2026 AISC to $3,300–$3,500/oz.

$BNTXMed

BioNTech Ended a Cancer Vaccine Trial. What Does it Mean for its mRNA Strategy?

BioNTech (NASDAQ:BNTX) halted a mid-stage trial of its mRNA cancer vaccine, autogene cevumeran, due to an overall survival imbalance. The decision raises concerns about its mRNA strategy in colorectal cancer and other 'cold' tumors. BioNTech plans to continue other trials, including one for pancreatic cancer and BNT113 for head and neck cancer. The company also focuses on diversifying its oncology pipeline. According to Reuters, the news caused a 7.5% drop in BioNTech's US-listed shares.

$VOW3.DEMed

HISTORIC TURN: Volkswagen To Produce Components For Israel’s Iron Dome System In Germany

Volkswagen (VW) plans to produce components for Israel's Iron Dome missile defense system at its Osnabrück, Germany factory. The move is part of VW's restructuring efforts amid economic challenges and competition. The project involves a joint venture with Israeli defense company Rafael and the German state of Lower Saxony, aiming to overcome opposition from Qatar's sovereign wealth fund, a VW stakeholder. This marks VW's return to defense-related manufacturing as European defense spending rises.